Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology.
Publication
, Journal Article
Wierda, WG; Byrd, JC; Abramson, JS; Bilgrami, SF; Bociek, G; Brander, D; Brown, J; Chanan-Khan, AA; Chavez, JC; Coutre, SE; Davis, RS; Hill, B ...
Published in: J Natl Compr Canc Netw
February 2020
Chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are characterized by a progressive accumulation of leukemic cells in the peripheral blood, bone marrow, and lymphoid tissues. Treatment of CLL/SLL has evolved significantly in recent years because of the improved understanding of the disease biology and the development of novel targeted therapies. In patients with indications for initiating treatment, the selection of treatment should be based on the disease stage, patient's age and overall fitness (performance status and comorbid conditions), and cytogenetic abnormalities. This manuscript discusses the recommendations outlined in the NCCN Guidelines for the diagnosis and management of patients with CLL/SLL.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
February 2020
Volume
18
Issue
2
Start / End Page
185 / 217
Location
United States
Related Subject Headings
- United States
- Transplantation, Homologous
- Remission Induction
- Prognosis
- Organizations, Nonprofit
- Oncology & Carcinogenesis
- Neoplasm Staging
- Neoplasm Recurrence, Local
- Mutation
- Medical Oncology
Citation
APA
Chicago
ICMJE
MLA
NLM
Wierda, W. G., Byrd, J. C., Abramson, J. S., Bilgrami, S. F., Bociek, G., Brander, D., … Sundar, H. (2020). Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 18(2), 185–217. https://doi.org/10.6004/jnccn.2020.0006
Wierda, William G., John C. Byrd, Jeremy S. Abramson, Syed F. Bilgrami, Greg Bociek, Danielle Brander, Jennifer Brown, et al. “Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw 18, no. 2 (February 2020): 185–217. https://doi.org/10.6004/jnccn.2020.0006.
Wierda WG, Byrd JC, Abramson JS, Bilgrami SF, Bociek G, Brander D, et al. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020 Feb;18(2):185–217.
Wierda, William G., et al. “Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw, vol. 18, no. 2, Feb. 2020, pp. 185–217. Pubmed, doi:10.6004/jnccn.2020.0006.
Wierda WG, Byrd JC, Abramson JS, Bilgrami SF, Bociek G, Brander D, Brown J, Chanan-Khan AA, Chavez JC, Coutre SE, Davis RS, Fletcher CD, Hill B, Kahl BS, Kamdar M, Kaplan LD, Khan N, Kipps TJ, Lim MS, Ma S, Malek S, Mato A, Mosse C, Shadman M, Siddiqi T, Stephens D, Sundaram S, Wagner N, Dwyer M, Sundar H. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020 Feb;18(2):185–217.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
February 2020
Volume
18
Issue
2
Start / End Page
185 / 217
Location
United States
Related Subject Headings
- United States
- Transplantation, Homologous
- Remission Induction
- Prognosis
- Organizations, Nonprofit
- Oncology & Carcinogenesis
- Neoplasm Staging
- Neoplasm Recurrence, Local
- Mutation
- Medical Oncology